Spaulding, Caitlin N.
Klein, Roger D.
Ruer, Ségolène
Kau, Andrew L.
Schreiber, Henry L.
Cusumano, Zachary T.
Dodson, Karen W.
Pinkner, Jerome S.
Fremont, Daved H.
Janetka, James W.
Remaut, Han
Gordon, Jeffrey I.
Hultgren, Scott J.
Article History
Received: 5 January 2017
Accepted: 22 May 2017
First Online: 14 June 2017
Competing interests
: J.W.J. and S.J.H. are inventors on US patent US8937167 B2, which covers the use of mannoside-based FimH ligand antagonists for the treatment of disease. J.W.J. and S.J.H. have ownership interest in Fimbrion Therapeutics, and may benefit if the company is successful in marketing mannosides.